University of Buffalo Investigators Contribute to the Global Trial Leading to the Approval of Fiasp®

Two clinical investigators from the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo (UB) participated in a successful worldwide Novo Nordisk-sponsored clinical trial, confirming that a fast-acting insulin is safe for children with...

Pin It on Pinterest